FDA Will Not Reverse Stance on Zicam

October 26, 2009 - Matrixx Initiatives, Inc. stated that the FDA will not change its position regarding Zicam Nasal Cold Remedies. Earlier this year the FDA sent Matrixx a warning letter regarding its nasal spray and nasal gel cold remedies. The warning letter stated that the FDA had numerous reports of anosmia following the use of Zicam products. Matrixx voluntarily recalled its products following the warning.